WO1999065448A3 - Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation - Google Patents

Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation Download PDF

Info

Publication number
WO1999065448A3
WO1999065448A3 PCT/FR1999/001445 FR9901445W WO9965448A3 WO 1999065448 A3 WO1999065448 A3 WO 1999065448A3 FR 9901445 W FR9901445 W FR 9901445W WO 9965448 A3 WO9965448 A3 WO 9965448A3
Authority
WO
WIPO (PCT)
Prior art keywords
beads
cosmetic
methods
preparing same
dermopharmaceutical composition
Prior art date
Application number
PCT/FR1999/001445
Other languages
English (en)
Other versions
WO1999065448A2 (fr
Inventor
Karim Ioulalen
Rosanne Raynal
Original Assignee
Karim Ioulalen
Rosanne Raynal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527477&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1999065448(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Karim Ioulalen, Rosanne Raynal filed Critical Karim Ioulalen
Priority to CA2341580A priority Critical patent/CA2341580C/fr
Priority to DE69926862T priority patent/DE69926862T2/de
Priority to AT99925113T priority patent/ATE302614T1/de
Priority to AU41510/99A priority patent/AU4151099A/en
Priority to EP99925113A priority patent/EP1030687B1/fr
Priority to US09/719,852 priority patent/US6572892B1/en
Publication of WO1999065448A2 publication Critical patent/WO1999065448A2/fr
Publication of WO1999065448A3 publication Critical patent/WO1999065448A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Abstract

Une composition solide anhydre comprend au moins une cire hydrophobe, une huile et du talc. Elle se présente de préférence sous forme de perles d'une taille comprise entre 1 et 10000 microns. Les perles peuvent contenir un principe actif cosmétique ou pharmaceutique, des pigments ou un composant agro-alimentaire. Le procédé pour la préparation des perles est décrit.
PCT/FR1999/001445 1998-06-17 1999-06-16 Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation WO1999065448A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA2341580A CA2341580C (fr) 1998-06-17 1999-06-16 Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation
DE69926862T DE69926862T2 (de) 1998-06-17 1999-06-16 Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
AT99925113T ATE302614T1 (de) 1998-06-17 1999-06-16 Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
AU41510/99A AU4151099A (en) 1998-06-17 1999-06-16 Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
EP99925113A EP1030687B1 (fr) 1998-06-17 1999-06-16 Composition cosmetique ou dermo-pharmaceutique sous forme de perles hydrophobes et procedes pour la preparation
US09/719,852 US6572892B1 (en) 1998-06-17 1999-06-16 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR98/07612 1998-06-17
FR9807612A FR2779962B1 (fr) 1998-06-17 1998-06-17 Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation

Publications (2)

Publication Number Publication Date
WO1999065448A2 WO1999065448A2 (fr) 1999-12-23
WO1999065448A3 true WO1999065448A3 (fr) 2000-02-17

Family

ID=9527477

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1999/001445 WO1999065448A2 (fr) 1998-06-17 1999-06-16 Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation

Country Status (10)

Country Link
US (1) US6572892B1 (fr)
EP (1) EP1030687B1 (fr)
AT (1) ATE302614T1 (fr)
AU (1) AU4151099A (fr)
CA (1) CA2341580C (fr)
DE (1) DE69926862T2 (fr)
DK (1) DK1030687T3 (fr)
ES (1) ES2247804T3 (fr)
FR (1) FR2779962B1 (fr)
WO (1) WO1999065448A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
US6858666B2 (en) 2002-03-04 2005-02-22 Aveka, Inc. Organogel particles
US6737394B2 (en) * 2002-03-04 2004-05-18 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Isotropic cleansing composition with benefit agent particles
FR2852843B1 (fr) * 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
WO2005097061A1 (fr) * 2004-04-01 2005-10-20 Procyte Corporation Complexes cuivre-peptide encapsules ainsi que compositions et procedes associes
FR2879930B1 (fr) * 2004-12-23 2007-08-31 Oralance Pharma Sa Nouveau systeme galenique pour le transport d'actif, procede de preparation et utilisation
TW200700107A (en) * 2005-03-16 2007-01-01 Procyte Corp Methods and compositions for preventing and treating aging or photodamaged skin
US7622132B2 (en) * 2005-06-27 2009-11-24 Elc Management, Llc Encapsulated cosmetic composition
US8236333B2 (en) * 2005-10-19 2012-08-07 Unirem, Inc. Active agent delivery and/or odor retentive composition and methods of use thereof
KR20070044879A (ko) * 2005-10-26 2007-05-02 주식회사 피앤아이 금속, 합금 및 세라믹 나노 입자가 균일하게 진공 증착된파우더의 형성 방법 및 그 제조 장치
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
US9145221B2 (en) 2012-03-20 2015-09-29 La Prairie, Inc. Convertible two compartment container
EP2964243B1 (fr) 2013-03-06 2022-11-23 Capsugel Belgium NV Particules lipidiques solides de curcumine et procédés de préparation et utilisation
US20170112762A1 (en) 2014-06-10 2017-04-27 Capsugel Belgium Nv Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
ES2602497T3 (es) 2014-08-14 2017-02-21 Capsugel Belgium Nv Aparato y proceso para verter materiales particulados
EP3226845A1 (fr) 2014-12-04 2017-10-11 Capsugel Belgium NV Formulations multiparticulaires lipidiques
WO2016105498A1 (fr) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Méthodes et compositions pour inhiber ou prévenir les effets néfastes des antibiotiques oraux
US10722527B2 (en) 2015-04-10 2020-07-28 Capsugel Belgium Nv Abiraterone acetate lipid formulations
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
FR3075633B1 (fr) 2017-12-22 2019-12-06 Lvmh Recherche Compositions cosmetiques comprenant des spheroides anhydres disperses dans une phase siliconee
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
WO2019183209A1 (fr) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Agents au phosphatase alcaline pour le traitement de troubles dus à une exposition à des radiations
FR3091164B1 (fr) * 2018-12-31 2021-12-10 Lvmh Rech Composition cosmétique solide comprenant des sphéroïdes anhydres en dispersion dans une phase continue aqueuse solide
CN114650833A (zh) 2019-09-13 2022-06-21 芬奇治疗控股有限责任公司 用于治疗孤独症谱群障碍的组合物和方法
US20220370392A1 (en) 2019-10-16 2022-11-24 Aouatef Bellamine Method and Composition for Increasing Muscle Protein Synthesis
EP4045630A1 (fr) 2019-10-18 2022-08-24 Finch Therapeutics Holdings LLC Compositions et procédés pour administrer un métabolite bactérien à un sujet
WO2021097288A1 (fr) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions et méthodes de traitement de maladies neurodégénératives
WO2021142347A1 (fr) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions et procédés relatifs à la stéatohépatite non alcoolique (nash)
WO2021142353A1 (fr) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions et méthodes pour le traitement de l'hépatite b (vhb) et de l'hépatite d (vhd)
WO2021142358A1 (fr) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions et méthodes pour le traitement de l'encéphalopathie hépatique (eh)
WO2021202806A1 (fr) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprenant un microbiome fécal non viable et leurs méthodes d'utilisation
WO2022178294A1 (fr) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions et méthodes pour fournir des acides biliaires secondaires à un sujet

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR885716A (fr) * 1941-09-02 1943-09-23 Vasenolwerke Dr Arthur Kopp Ko Agent protecteur pour la peau, et procédé pour sa préparation
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
FR2486800A1 (fr) * 1980-07-21 1982-01-22 Oreal Composition cosmetique sous forme d'une creme anhydre de consistance onctueuse
US4800076A (en) * 1987-03-13 1989-01-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions
EP0720845A1 (fr) * 1995-01-05 1996-07-10 L'oreal Composition cosmétique sous forme de pâte souple et procédé de préparation
WO1996029056A1 (fr) * 1995-03-17 1996-09-26 Gebro Broschek Gmbh Composition pharmaceutique d'application topique, son procede de production et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804249A2 (fr) * 1994-03-15 1997-11-05 Brown University Research Foundation Systeme de liberation de genes polymeres

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR885716A (fr) * 1941-09-02 1943-09-23 Vasenolwerke Dr Arthur Kopp Ko Agent protecteur pour la peau, et procédé pour sa préparation
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
FR2486800A1 (fr) * 1980-07-21 1982-01-22 Oreal Composition cosmetique sous forme d'une creme anhydre de consistance onctueuse
US4800076A (en) * 1987-03-13 1989-01-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions
EP0720845A1 (fr) * 1995-01-05 1996-07-10 L'oreal Composition cosmétique sous forme de pâte souple et procédé de préparation
WO1996029056A1 (fr) * 1995-03-17 1996-09-26 Gebro Broschek Gmbh Composition pharmaceutique d'application topique, son procede de production et son utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
V.D. VILIVALAM ET AL.: "development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres", JOURNAL OF MICROENCAPSULATION, vol. 11, no. 4, 1 July 1994 (1994-07-01), London /GB), pages 455 - 470, XP000451975 *

Also Published As

Publication number Publication date
US6572892B1 (en) 2003-06-03
CA2341580C (fr) 2012-04-10
DE69926862T2 (de) 2006-06-01
AU4151099A (en) 2000-01-05
FR2779962B1 (fr) 2002-12-06
FR2779962A1 (fr) 1999-12-24
EP1030687B1 (fr) 2005-08-24
DE69926862D1 (de) 2005-09-29
WO1999065448A2 (fr) 1999-12-23
ES2247804T3 (es) 2006-03-01
EP1030687A2 (fr) 2000-08-30
ATE302614T1 (de) 2005-09-15
CA2341580A1 (fr) 1999-12-23
DK1030687T3 (da) 2006-01-16

Similar Documents

Publication Publication Date Title
WO1999065448A3 (fr) Composition cosmetique ou dermo-pharmaceutique sous forme de perles et procedes pour la preparation
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
WO1998038984A3 (fr) Preparations d'agents pharmaceutiques hydrophobes
PL322195A1 (en) Novel composition in the form of oil-in-water emulsion for local application
CA2010919A1 (fr) Cosmetiques en batonnets
AU2449195A (en) Self-emulsifiable formulation producing an oil-in-water emulsion
AU7408991A (en) Aqueous cosmetic or dermo-pharmaceutical composition containing, in suspension, hydrated spheroids of a hydrophilic lipidic substance
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
PL340926A1 (en) Polyethylene glycol matrix granules for drugs in the form of fatty, oily or highly viscous substances
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
IT1281220B1 (it) Imballaggio per prodotti astiformi, in particolare come sigarette, o simili, nonche' metodo e dispositivo per la fabbricazione dello stesso
AU2001235699A1 (en) Cosmetic or dermopharmaceutical compositions containing the val-trp dipeptide
FR2750047B1 (fr) Composition cosmetique ou dermatologique sous forme d'un gel aqueux de forte viscosite
HUP0001551A3 (en) Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU4834596A (en) Cosmetic or pharmaceutical compositions containing an ozonide-enriched natural vegetable oil, and uses thereof
WO1997002002A3 (fr) Utilisation de polyolpoly-12-hydroxystearates
ITRM940297A0 (it) "dispositivo per la trasmissione di comandi manuali di accelerazione, frenatura e simili".
AU2712197A (en) Micellar aqueous composition and method for solubilizing hydrophobic drug
AU2565395A (en) Cosmetic product containing hempseed oil and method for manufacturing the same
WO2001047474A3 (fr) Utilisation de desodorisants nanometriques
AU2001235706A1 (en) Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
IT240707Y1 (it) Struttura per l'introduzione di mezzi in pressione in assi, alberio simili
WO2000004874A3 (fr) Capsules de gelatine molle contenant de l'huile d'olive

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999925113

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999925113

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2341580

Country of ref document: CA

Ref country code: CA

Ref document number: 2341580

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09719852

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 1999925113

Country of ref document: EP